| SHIN NIPPON BIOMED.LAB. |
| Japan |
| Gesundheit |
| JP3379950003 / A0BMJN |
| YB3 (Frankfurt) |
| FRA:YB3, ETR:YB3, YB3:GR |
| - |
| https://www.snbljapan.com.. |
|
Shin Nippon Biomedical Laboratories Ltd. operates as a prominent player in the life sciences industry, focusing on providing comprehensive clinical and preclinical research services. The company's primary function is to support pharmaceutical compani..
>Volltext.. |
| 327.24 Mio. EUR |
| 470.95 Mio. EUR |
| 173.44 Mio. EUR |
| 29.38 Mio. EUR |
| 22.06 Mio. EUR |
| 0.53 EUR |
| 229.54 Mio. EUR |
| 85.17 Mio. EUR |
| - |
| 0.44 |
| -9.63% |
| -28.6% |
| 0.28 EUR |
| 3.42% |
| 3.5% |
| 30.03.26 - 0.1634772€ 29.09.25 - 0.113952€ >weitere anzeigen... |
| - |
| SHIN NIPPON BIOMED, SHIN NIPPON BIOMEDICAL, SNBL JAPAN |
| 05.04.26 |
|